We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+22.14%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.77B
AUM Growth
+$360M
Cap. Flow
+$138M
Cap. Flow %
7.81%
Top 10 Hldgs %
8.01%
Holding
874
New
148
Increased
244
Reduced
232
Closed
198

Top Buys

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$9.45M
2
SNAP icon
Snap
SNAP
+$8.6M
3
NU icon
Nu Holdings
NU
+$7.95M
4
SEDG icon
SolarEdge
SEDG
+$6.9M
5
STLA icon
Stellantis
STLA
+$5.73M

Top Sells

Rank Stock Value
1
SWKS icon
Skyworks Solutions
SWKS
+$8.29M
2
TRGP icon
Targa Resources
TRGP
+$7.01M
3
HUM icon
Humana
HUM
+$6.85M
4
AXSM icon
Axsome Therapeutics
AXSM
+$5.97M
5
ONON icon
On Holding
ONON
+$5.59M

Sector Composition

Rank Sector Weight
1 Technology 22.93%
2 Healthcare 15.99%
3 Consumer Discretionary 15.58%
4 Industrials 12.08%
5 Financials 10.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATXS
601
DELISTED
Astria Therapeutics
ATXS
$293K 0.02%
54,642
+25,935
+90% +$126K
IMXI icon
602
International Money Express
IMXI
$357M
$292K 0.02%
28,955
-7,814
-21% -$89.2K
TPB icon
603
Turning Point Brands
TPB
$1.45B
$288K 0.02%
3,799
-5,433
-59% -$370K
ESQ icon
604
Esquire Financial Holdings
ESQ
$1.12B
$285K 0.02%
3,015
-10
-0.3% -$864
PDS
605
Precision Drilling
PDS
$999M
$283K 0.02%
5,983
-12,293
-67% -$547K
SHAK icon
606
Shake Shack
SHAK
$2.53B
$281K 0.02%
2,000
-8,000
-80% -$871K
BGS icon
607
B&G Foods
BGS
$287M
$281K 0.02%
66,369
+43,208
+187% +$226K
BHC icon
608
Bausch Health
BHC
$2.57B
$279K 0.02%
+41,845
New +$215K
OM icon
609
Outset Medical
OM
$84.7M
$272K 0.02%
+14,159
New +$221K
CMRE icon
610
Costamare
CMRE
$1.88B
$271K 0.02%
29,756
-23,486
-44% -$209K
BJRI icon
611
BJ's Restaurants
BJRI
$1.42B
$271K 0.02%
6,072
-7,420
-55% -$293K
NABL icon
612
N-able
NABL
$882M
$269K 0.02%
33,254
-29,507
-47% -$220K
SOBO
613
South Bow Corp
SOBO
$7.74B
$269K 0.02%
10,387
-82,602
-89% -$2.1M
NPCE icon
614
Neuropace
NPCE
$439M
$264K 0.01%
+23,695
New +$296K
TSAT icon
615
Telesat
TSAT
$567M
$262K 0.01%
10,709
+96
+0.9% +$1.69K
ACMR icon
616
ACM Research
ACMR
$5.42B
$257K 0.01%
9,942
-111,660
-92% -$2.51M
VRT icon
617
Vertiv
VRT
$93B
$257K 0.01%
+2,000
New +$194K
GIB icon
618
CGI
GIB
$15.1B
$256K 0.01%
2,446
-3,669
-60% -$387K
FTK icon
619
Flotek Industries
FTK
$852M
$255K 0.01%
17,246
SEI
620
Solaris Energy Infrastructure
SEI
$3.15B
$252K 0.01%
8,900
-76,138
-90% -$1.79M
PRTA icon
621
Prothena Corp
PRTA
$425M
$251K 0.01%
41,281
-109,035
-73% -$818K
DENN
622
DELISTED
Denny's
DENN
$249K 0.01%
+60,682
New +$233K
ATO icon
623
Atmos Energy
ATO
$28.8B
$247K 0.01%
1,600
-15
-0.9% -$2.33K
RRGB icon
624
Red Robin
RRGB
$145M
$237K 0.01%
40,972
CMP icon
625
Compass Minerals
CMP
$1.23B
$234K 0.01%
+11,628
New +$188K

Similar funds

PDT Partners's Q2 2025 Portfolio in Review

As of Q2 2025, PDT Partners held 874 positions worth $1.77B, up 26% from $1.41B the previous quarter. Its ten largest holdings account for 8% of the portfolio.

PDT Partners deployed $138M of net new capital in Q2 2025, opening 148 new positions and adding to 244 existing holdings. Its largest new stake was UBS Group: 305,378 shares worth $10.3M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Skyworks Solutions, an estimated $8.29M trimmed.

  • PDT Partners's largest Q2 2025 buy was UBS Group: 305,378 shares worth $10.3M.
  • PDT Partners added most to Snap in Q2 2025, an estimated $8.6M increase.
  • PDT Partners's biggest Q2 2025 reduction was Skyworks Solutions, cutting an estimated $8.29M.
  • PDT Partners fully exited Axsome Therapeutics in Q2 2025, selling an estimated $5.97M.
  • PDT Partners's ten largest holdings make up 8% of its $1.77B portfolio in Q2 2025.
  • PDT Partners opened 148 new positions and closed 198 in Q2 2025.
  • PDT Partners's portfolio value rose 26% quarter-over-quarter to $1.77B.

Based on PDT Partners's 13F filing for Q2 2025, filed 14 Aug 2025.